Pfizer (PFE), a global pharmaceutical giant that was once a pandemic darling, is now facing turbulence. Following a period of extraordinary vaccine-driven revenue, the company now faces a more ...

Pfizer's Sally Susman, a pioneer in corporate communications, is leaving her job the end of 2025.Susman played a key role in building public trust during Pfizer's COVID-19 vaccine development.She ...

The Justice Department changed its policy on foreign corruption cases, which might have put an end to investigations into the pharmaceutical company.

Pfizer Inc. (NYSE: PFE) today announced changes to its executive leadership team to further advance its aspirations to discover and develop new medici ...

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

Pfizer projects 2025 revenues of $61-$64 billion, adjusted EPS of $2.80-$3.00, and $24-$26 billion in combined SI&A and R&D expenses while reaffirming its 2024 guidance.

Pfizer said Tuesday it does not expect the Trump administration to make major changes to vaccine policy next year even with vaccine skeptic Robert F. Kennedy Jr. as the nominee to run the ...

Pfizer faces a $1 billion sales hit in 2025 from IRA reforms, flat EPS and revenue forecasts, and long-term risks tied to patent expirations.

Activist investor Starboard Value has taken a $1 billion stake in beleaguered drugmaker Pfizer Inc. and is seeking a turnaround, the Wall Street Journal reported late Sunday. Citing unnamed ...

Pfizer CEO Albert Bourla, under pressure from activist hedge fund Starboard Value, made his case to Wall Street on Tuesday that the drugmaker's turnaround is succeeding after it reported a higher ...

(RTTNews) - Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer (PFE) and is advocating for significant changes to improve the company's underwhelming performance, the ...